William E. Pierceall
Impact in
- Oncology top 2%
- Cancer-related Molecular Pathways
- Colorectal Cancer Screening and Detection
- Dermatology top 1%
- Skin Protection and Aging
Papers in ⓘ
- Hematology 25
- Multiple Myeloma Research and Treatments 19
- Acute Myeloid Leukemia Research 6
- Oncology 24
- Cancer-related Molecular Pathways 6
- Peptidase Inhibition and Analysis 4
- Co-authors
- Honnavara N. Ananthaswamy (3 shared papers)Leonard H. Goldberg (3 shared papers)Tapas Mukhopadhyay (2 shared papers)Jonathan J. Harrington (1 shared paper)Stephen N. Thibodeau (1 shared paper)David A. Ahlquist (1 shared paper)Kevin A. Boynton (1 shared paper)Joel Skoletsky (1 shared paper)
- Journals
- Blood (12 papers)Molecular Cancer Therapeutics (2 papers)Molecular Carcinogenesis (2 papers)Clinical Cancer Research (1 paper)British Journal of Haematology (1 paper)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
William E. Pierceall
54 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 117
- Oncology 1.1k
- Dermatology 331
- Hematology 371
- Cancer Research 351
- Pathology and Forensic Medicine 390
Countries citing papers authored by William E. Pierceall
This map shows the geographic impact of William E. Pierceall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William E. Pierceall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William E. Pierceall more than expected).
Fields of papers citing papers by William E. Pierceall
This network shows the impact of papers produced by William E. Pierceall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William E. Pierceall. The network helps show where William E. Pierceall may publish in the future.
Co-authors
The 25 scholars most cited alongside William E. Pierceall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 399 | |
| 2 | 1990 | 306 | |
| 3 | 1991 | 212 | |
| 4 | 2012 | 162 | |
| 5 | 2019 | 144 | |
| 6 | High frequency of p53 mutations in ultraviolet radiation-induced murine skin tumors: evidence for strand bias and tumor heterogeneity. | 1993 | 143 |
| 7 | Frequent alterations in E-cadherin and alpha- and beta-catenin expression in human breast cancer cell lines. | 1995 | 119 |
| 8 | 1991 | 100 | |
| 9 | 2020 | 83 | |
| 10 | 1999 | 72 | |
| 11 | 2014 | 58 | |
| 12 | 2012 | 54 | |
| 13 | N-ras mutation in ultraviolet radiation-induced murine skin cancers. | 1992 | 52 |
| 14 | 1991 | 46 | |
| 15 | 2013 | 43 | |
| 16 | Loss of DCC expression in neuroblastoma is associated with disease dissemination. | 1996 | 34 |
| 17 | 2021 | 34 | |
| 18 | 1994 | 33 | |
| 19 | 2019 | 33 | |
| 20 | 2014 | 31 |
About William E. Pierceall
William E. Pierceall is a scholar working on Hematology, Oncology, Molecular Biology, Cancer Research and Biophysics, having authored 55 papers that have together received 2.5k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (19 papers), Multiple Myeloma Research and Treatments (19 papers), Acute Myeloid Leukemia Research (6 papers), Histone Deacetylase Inhibitors Research (6 papers), Cancer-related Molecular Pathways (6 papers), Genetic factors in colorectal cancer (4 papers), Peptidase Inhibition and Analysis (4 papers) and HIV/AIDS drug development and treatment (4 papers). The work is most often cited by research in Oncology (1.1k citations), Dermatology (331 citations), Hematology (371 citations), Cancer Research (351 citations) and Pathology and Forensic Medicine (390 citations). William E. Pierceall has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Honnavara N. Ananthaswamy, Leonard H. Goldberg, Tapas Mukhopadhyay, Jonathan J. Harrington, Stephen N. Thibodeau, David A. Ahlquist, Kevin A. Boynton, Joel Skoletsky, Douglas W. Mahoney and Anthony P. Shuber. Their work appears in journals such as Blood, Molecular Cancer Therapeutics, Molecular Carcinogenesis, Clinical Cancer Research and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.